Primerdesign partners with VGS Group in France

Commercial agreement includes molecular diagnostics for the growing aquaculture and aquamarine market

Paris, France and Camberley, UK – 17 January 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its molecular testing division, Primerdesign Ltd (“Primerdesign”), has signed an exclusive commercial agreement with Atothis SARL, part of VGS Invest Holding Sarl Group (“VGS Group”), for the distribution of certain molecular diagnostic products in France for the growing aquaculture and aquamarine markets. France is the second largest aquaculture producer in the EU, with shellfish production alone contributing a total of 155,000 tonnes a year valued at approximately €550 million to the French economy.

http://novacyt.com/wp-content/uploads/2020/01/Primerdesign-partners-with-VGS-Group-in-France.pdf